![Andrew Robbins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 23 M $ al 31/05/2026
Andrew R.
Robbins is President, Chief Executive Officer & Director at Cogent Biosciences, Inc. since 2020.
Mr. Robbins is also an Independent Director at Turmeric Acquisition Corp.
since 2020.
Former roles include Independent Director at Harpoon Therapeutics, Inc. from 2020 to 2024; Chief Operating Officer at Array BioPharma, Inc. from 2015 to 2019; Senior Vice President-Commercial Operations at Pfizer Inc. from 2012 to 2015; General Manager & Vice President at Hospira, Inc. from 2007 to 2012; and Director positions at Cytograft Tissue Engineering, Inc., StemCor Systems, Inc., and Fate Therapeutics, Inc. Education includes undergraduate studies at Swarthmore College and an MBA from Kellogg School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
COGENT BIOSCIENCES, INC. 0,38 % | 19/05/2026 | 657.503 ( 0,38 % ) | 23 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TURMERIC ACQUISITION CORP. | Director/Miembro de la Junta | 01/10/2020 |
| COGENT BIOSCIENCES, INC. | Director Ejecutivo | 23/10/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Director/Miembro de la Junta | 11/03/2024 |
| ARRAY TECHNOLOGIES, INC. | Director de Operaciones | 01/01/2019 |
| PFIZER INC. | Director de Operaciones | 01/03/2015 |
| HOSPIRA, INC. | Corporate Officer/Principal | 01/07/2012 |
StemCor Systems, Inc.
 StemCor Systems, Inc. Medical SpecialtiesHealth Technology Develops proprietary and minimally-invasive bone marrow collection systems | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs, IV sets and clinical integration & software, infusion pumps and implementation services | Health Technology |
Cytograft Tissue Engineering, Inc.
 Cytograft Tissue Engineering, Inc. Pharmaceuticals: MajorHealth Technology Develops cardiovascular medicine | Health Technology |
StemCor Systems, Inc.
StemCor Systems, Inc. Medical SpecialtiesHealth Technology Develops proprietary and minimally-invasive bone marrow collection systems | Health Technology |
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Swarthmore College
 Swarthmore College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Turmeric Acquisition Corp.
 Turmeric Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
